https://pubmed.ncbi.nlm.nih.gov/38113655

The review discusses the potential of SIRT2-selective inhibitors as a therapeutic strategy for cancer treatment, highlighting their regulatory roles and molecular mechanisms in cancer and the results of in vitro and in vivo testing.